Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II

[pdf]Blumenschein JCO 2008_26-11_1879 (193 Ko)[/pdf]